Immunotherapy of malignant disease (Part 2).
D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use; D005770:Gastrointestinal Neoplasms / Q000628:therapy; D006168:Guinea Pigs; D006801:Humans; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D012343:RNA, Transfer / Q000008:administration & dosage; D011817:Rabbits; D051381:Rats; D014165:Transfer Factor / Q000008:administration & dosage
D001500:BCG Vaccine; D014165:Transfer Factor; D012343:RNA, Transfer